Chinese Medical Device Provider Blue Sail Picks Up 10.16% Stake In Artificial Heart Developer

Eudora Wang
June 19, 2019 — 12:31 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: acquisition America artificial heart Blue Sail China chinese europe guangdong healthcare investment IPR manufacturing medicine shenzhen Suzhou Tongxin Medical

Related News:

China Establishes Nationwide Regulations for Commercial Use of Autonomous Vehicles

December 6, 2023 — 01:50

China’s Energy Sector Invests in Hydrogen Projects to Achieve National Dual Carbon Goals

December 4, 2023 — 23:32

ByteDance’s ChatGPT-Powered AI Chatbot Cici Tops Charts in Emerging Markets

November 29, 2023 — 23:23

ByteDance to Dissolve Gaming Unit After Failing to Find a Buyer

November 28, 2023 — 03:29

Huawei Spins Off Intelligent Automotive Solutions Unit To Secure Fresh Funding

November 27, 2023 — 23:45

ByteDance Establishes New AI Division To Accelerate Consumer Product Deployment

November 27, 2023 — 23:10

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

ByteDance to Sell Moonton Gaming Studio in Strategic Retreat From Gaming

November 23, 2023 — 00:00

Tencent-Backed WeBank Saw Rapid Revenue and Profit Expansion

November 20, 2023 — 23:07